Cat.#: ASSD-124
Description | Fluorescent β2-adrenoceptor antagonist (apparent KD values are 7.68, 6.42 and <4.0 for β2, β1 and β3 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. Exhibits no intrinsic agonist activity. |
Size | 500 μg |
Applications | For imaging at β1 / β2 / β3 adrenoceptors use solutions up to 100 nM. |
Molecule Weight | 736 |
Purity | >95% |
Solubility | Soluble in DMSO |
Excitation | 488 nm |
Emission | 525/550 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
ASSD-224 | Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) | 10 mL | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-140 | A2B covalent ligand (AC140) | 50 μg | inquiry |
ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
ASSD-225 | Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) | 10 mL | inquiry |
ASSD-126 | Fluorescent H2 antagonist [aminopotentidine] (AC126) | 50 μg | inquiry |
ASSD-215 | 1-Pyrenylmethyl Methanethiosulfonate (AC215) | 10 mg | inquiry |
ASSD-139 | Adenosine A1AR Affinity-Based Probe (AfBP) (AC139) | 50 μg | inquiry |
ASSD-162 | Nile Red (AC162) | 25 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.